BioLineRx Ltd.
BLRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001498403
No open-market purchases or sales by BioLineRx Ltd. insiders were filed in the last 90 days; 14 institutions reported holding it in 13F filings for Q2 2026, worth $206.7K in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in BioLineRx Ltd. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 32
- 0 vs. Q3 2024
- Shares held
- 2.01M
- −492.5K (−19.7%) vs. Q3 2024
- Total value
- $435.9K
- −$907.8K (−67.6%) vs. Q3 2024
- New holders
- 10
- 6 more added
- Sold out
- 10
- 6 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BLRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 14 | $206.7K |
| Q1 2026 | 13 | $45.2K |
| Q4 2025 | 14 | $135.6K |
| Q3 2025 | 14 | $104.3K |
| Q2 2025 | 17 | $302.1K |
| Q1 2025 | 12 | $28.0K |
| Q4 2024 | 32 | $435.9K |
| Q3 2024 | 32 | $1.34M |
| Q2 2024 | 31 | $2.42M |
| Q1 2024 | 28 | $1.47M |
| Q4 2023 | 29 | $1.75M |
| Q3 2023 | 29 | $2.46M |
| Q2 2023 | 26 | $1.97M |
| Q1 2023 | 20 | $2.91M |
| Q4 2022 | 18 | $3.37M |
| Q3 2022 | 28 | $10.3M |
| Q2 2022 | 28 | $1.36M |
| Q1 2022 | 26 | $1.99M |
| Q4 2021 | 30 | $5.09M |
| Q3 2021 | 30 | $6.69M |
| Q2 2021 | 30 | $4.01M |
| Q1 2021 | 29 | $13.5M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding BioLineRx Ltd.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Highbridge Capital Management LLC | 1,010,012 | $214.6K | 0.01% | +1,010,012 | New |
| Values First Advisors, Inc. | 166,449 | $35.6K | 0.02% | −31,067−15.7% | Reduced |
| Atria Wealth Solutions, Inc. | 94,133 | $20.1K | 0.00% | 00.0% | Unchanged |
| LPL Financial LLC | 92,000 | $19.7K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 87,215 | $18.5K | 0.00% | +69,183+383.7% | Added |
| Morgan Stanley | 79,102 | $16.9K | 0.00% | −118,435−60.0% | Reduced |
| BNP Paribas Arbitrage, SA | 57,340 | $12.3K | 0.00% | +57,340 | New |
| Orin Green Financial, LLC | – | $10.9K | 0.00% | – | – |
| Rhumbline Advisers | 42,961 | $9.14K | 0.00% | +10,350+31.7% | Added |
| Gradient Investments LLC | 41,400 | $8.86K | 0.00% | +11,400+38.0% | Added |
| Geode Capital Management, LLC | 39,993 | $8.50K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 35,310 | $7.56K | 0.00% | +35,310 | New |
| Rathbone Brothers plc | 31,666 | $6.78K | 0.00% | −8,154−20.5% | Reduced |
| Citigroup Inc | 31,337 | $6.66K | 0.00% | +31,337 | New |
| Watts Gwilliam & Co., LLC | 34,000 | $5.44K | 0.00% | +34,000 | New |
| Captrust Financial Advisors | 20,064 | $4.29K | 0.00% | +3,892+24.1% | Added |
| Royal Bank of Canada | 20,200 | $4.00K | 0.00% | +20,200 | New |
| Citadel Advisors LLC | 15,314 | $3.25K | 0.00% | +15,314 | New |
| Creative Planning | 12,982 | $2.78K | 0.00% | 00.0% | Unchanged |
| Nemes Rush Group LLC | 12,000 | $2.57K | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 11,935 | $2.54K | 0.00% | −1,100−8.4% | Reduced |
| Weaver Consulting Group | 11,000 | $2.35K | 0.00% | −18,745−63.0% | Reduced |
| Wealth Enhancement Advisory Services, LLC | 10,500 | $2.25K | 0.00% | 00.0% | Unchanged |
| Hibernia Wealth Partners, LLC | 10,000 | $2.14K | 0.00% | +10,000 | New |
| Neville Rodie & Shaw Inc | 10,000 | $2.00K | 0.00% | +10,000 | New |
| UBS Group AG | 9,196 | $1.97K | 0.00% | +8,212+834.6% | Added |
| Wells Fargo & Company | 5,535 | $1.18K | 0.00% | −29,500−84.2% | Reduced |
| Geneos Wealth Management Inc. | 4,800 | $1.01K | 0.00% | +300+6.7% | Added |
| GWM Advisors LLC | 4,300 | $920 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 3,104 | $664 | 0.00% | +3,104 | New |
| Advisor Group Holdings, Inc. | 1,206 | $258 | 0.00% | 00.0% | Unchanged |
| Tradewinds Capital Management, LLC | 200 | $43 | 0.00% | 00.0% | Unchanged |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −866,495−100.0% | Sold out |
| Envestnet Asset Management Inc | 0 | $0 | 0.00% | −239,186−100.0% | Sold out |
| PVG Asset Management Corp | 0 | $0 | 0.00% | −157,215−100.0% | Sold out |
| Atria Investments LLC | 0 | $0 | 0.00% | −133,974−100.0% | Sold out |
| Cetera Investment Advisers | 0 | $0 | 0.00% | −80,158−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −44,135−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −21,326−100.0% | Sold out |
| Cutter & CO Brokerage, Inc. | 0 | $0 | 0.00% | −16,667−100.0% | Sold out |
| Baader Bank INC | 0 | $0 | 0.00% | −13,250−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −1−100.0% | Sold out |